Sample product 6

Sample product 6

£996

Engineered from the ground up, RoosterGEM are complete media built to solve key challenges in both viral and non-viral MSC and primary cell engineering.

Traditionally, genetic modification of primary cells has low efficiency of transfer requiring increased viral and non-viral agent costs, with significant time and resources allocated to media and process optimization.

RoosterGEM is a highly efficient Complete Genetic Engineering Medium, formulated to increase genetic engineering efficiencies, enabling a reduction in key raw material costs and more readily meet regulatory guidelines.

When paired with RoosterBio’s industrialized supply chain of high-volume Xeno-free hMSCs, ultra-productive expansion media, and cGMP-compatible processes – you enlist an end-to-end Genetic Engineering MSC-platform to streamline your transient or integrated gene transfer, de-risk your product & process development, and streamline your path to clinical translation.

المراجعات

لا توجد مراجعات بعد.

كن أول من يقيم “Sample product 6”

لن يتم نشر عنوان بريدك الإلكتروني. الحقول الإلزامية مشار إليها بـ *

انتقل إلى أعلى

Hi
Here you can see some frequently asked questions or contact us!

What passage are your cells?

Our human mesenchymal stem/stromal cells (hMSCs) are provided at a population doubling level (PDL) of 8-10 post-mononuclear isolation (Bone Marrow; Equivalent Passage 2) or 14-18 post-isolation from the perivascular region of Wharton’s Jelly (Umbilical Cord; Equivalent Passage 3). Due to variabilities of seeding and harvest densities we characterize our MSC “True Age” in terms of their PDL.

How often should I feed your cells?

A: There is no need to feed cells between passages. Our media is engineered to be a batch culture media, where no media exchange or feed is necessary when following our suggested protocols.

Are your vials sold from pooled donors?

No, we do not pool donors at any time during our production. Master Cell Banks (MCBs) are created from each donor source. Working Cell Banks (WCBs) are produced from our MCBs for general product sales.

What characterization do you provide for your hMSCs?

We characterize our hMSCs by following ISCT criteria: cell identity (surface marker expression), functional potency (angiogenic cytokine and IDO secretion), and trilineage differentiation (adipo-, osteo-, and chondrogenesis). This information is provided to allow customers to choose the optimal hMSC tissue type and donor for their specific application or target indication.